Effects of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial Tesamorelin, a growth hormone-releasing factor analogue, in HIV-infected patients with excess abdominal fat Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials Pharmacokinetics, pharmacodynamics, and safety of ipamorelin, a novel ghrelin mimetic peptide, in healthy volunteers Ipamorelin, the first selective growth hormone secretagogue Growth hormone-releasing hormone in the treatment of HIV-associated lipodystrophy Eligibility & terms of sale This material is sold to qualified laboratory and research buyers for lawful research use only
Compounded or custom peptides are not FDA-approved but are regulated to ensure quality and sterility but are not approved for medical purposes
Mousa SA, Al Momen A, Al Sayegh F, Al Jaouni S, Nasrullah Z, Al Saeed H,
Encourage diet sources of B where possible, and adherence to the injection schedule.
Cell (1993) 74(2):22736.10.1016/0092-8674(93)90414-L 13 ChuJGuiCYFanJTangXDQiaoRL
